Despite entering its maturation phase, the recombinant protein sector will continue to drive the growth of medical biotechnology over the next six years.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Cold atmospheric plasma treatment enhances recombinant model protein production in yeast Pichia pastoris
Scientific Reports Open Access 26 April 2023
-
Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations
Pharmaceutical Research Open Access 02 June 2020
-
Improved adsorption reactions, kinetics and stability for model and therapeutic proteins immobilised on affinity resins
Adsorption Open Access 16 May 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Reichert, J.M. & Paquette, C. Therapeutic recombinant proteins: trends in US approvals 1982-2002. Curr. Opin. Mol. Ther. 5, 139–147 (2003).
Reichert, J.M. Biopharmaceutical approvals in the US. Reg. Affairs J. Pharma 15, 491–497 (2004).
Reichert, J.M. & Pavlou, A. Monoclonal antibodies market. Nat. Rev. Drug Discovery 3, 383–384 (2004).
Reichert, J.M. Therapeutic monoclonal antibodies: trends in development and approval in the US. Curr. Opin. Mol. Ther. 4: 110–118 (2002).
Reichert, J.M. Monoclonal antibodies in the clinic. Nat. Biotechnol. 19, 819–822 (2001).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pavlou, A., Reichert, J. Recombinant protein therapeutics—success rates, market trends and values to 2010. Nat Biotechnol 22, 1513–1519 (2004). https://doi.org/10.1038/nbt1204-1513
Issue Date:
DOI: https://doi.org/10.1038/nbt1204-1513
This article is cited by
-
Cold atmospheric plasma treatment enhances recombinant model protein production in yeast Pichia pastoris
Scientific Reports (2023)
-
A green light-enhanced cytosolic protein delivery platform based on BODIPY-protein interactions
Nano Research (2023)
-
Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations
Pharmaceutical Research (2020)
-
Improved adsorption reactions, kinetics and stability for model and therapeutic proteins immobilised on affinity resins
Adsorption (2019)
-
A chicken bioreactor for efficient production of functional cytokines
BMC Biotechnology (2018)